A recent review by Poon et al. (2021) summarizes the potential in targeting BDNF expression with antidepressants to facilitate fear memory extinction in a depression paradigm that may also be used to alleviate anxiety-related pathology. This evidence concerns the gene BDNF and depressive symptom measurement.